Pharmagenesis, Inc.

Fujisawa Enters Research Agreement With Pharmagenesis

Fujisawa Pharmaceutical Co., Ltd., has executed a collaborative research agreement with Pharmagenesis, Inc., with regard to triptolide derivatives, novel and potent immunosuppressants created by Pharmagenesis. The agreement also gives Fujisawa an option to acquire the exclusive and worldwide (certain territories are under negotiation) development and marketing rights to Pharmagenesis’ compounds in the therapeutic areas of Read more about Fujisawa Enters Research Agreement With Pharmagenesis[…]